Battery Ventures, a global, technology focused investment firm, has acquired LI-COR Biosciences.

LI-COR makes engineered instrumentation systems for environmental research, agriculture, drug discover, protein research and therapeutics development. The firm offers two main business lines which include its environmental monitoring instrumentation, devices and software to analyze plants, atmosphere, and gas and soil, and its biotechnology business.

“We are excited to partner with LI-COR and the Biggs family in this transaction, particularly since we’ve been tracking the company and its growth since 2013,” said Jesse Feldman, a Battery Ventures general partner. “We look forward to helping LI-COR increase its market share and grow both organically and through targeted acquisitions.”

“Partnering with Battery, a well-capitalized firm with an extensive history of backing innovative analytical-instrument businesses, is the logical evolution for LI-COR,” added Greg Biggs, LI-COR current CEO.